N
Nanologica AB (publ)
STO:NICA
Nanologica AB (publ)
STO:NICA
Price:
0.37
SEK
-8.87%
Market Closed
Market Cap:
kr32.7m
Relative Value
The Relative Value of one NICA stock under the Base Case scenario is hidden SEK. Compared to the current market price of 0.37 SEK, Nanologica AB (publ) is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NICA Relative Value
HIDDEN
Multiples Across Competitors
NICA Competitors Multiples
Nanologica AB (publ) Competitors
Nanologica AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
N
|
Nanologica AB (publ)
STO:NICA
|
32.7m SEK | 1.4 | -0.7 | -0.9 | -0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.3B USD | 6.7 | 169.2 | 16.4 | 23.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.9B USD | 5.6 | 26.5 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178.6B USD | 6.1 | 21 | 14.2 | 14.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.7B USD | 10.1 | 30.7 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.1B USD | 5.7 | 18 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.2 | 16.7 | 11.4 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
40.3B EUR | 13.2 | 31.1 | 52.8 | 54.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
